🔎 Trials Near Me

Dachaigh › Degeneration Macular › Illinois

Sgrùdaidhean clionaigeach Degeneration Macular ann an Illinois

Tha 13 sgrùdaidhean airson Degeneration Macular a’ lorg phàirtichean aig làraichean ann an Illinois.

Bailtean ann an Illinois

Teacsa sgrùdaidh oifigeil (Beurla)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Illinois Retina Associates, Oak Park
  • Springfield Clinic, Springfield
A’ fastadhÌre 2/3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • University Retina, Lemont
A’ fastadhÌre 2/3
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06635148

A Study in Adults With Geographic Atrophy

  • University Retina and Macula Associates, P.C., Lemont
A’ fastadhÌre 2
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • University of Illinois at Chicago, Chicago
  • Retinal Vitreal Consultants, Chicago
  • The University of Chicago, Chicago
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Northwestern Medical Group, Chicago
  • The University of Chicago Medicine Duchossois Center for Advanced Medicine, Chicago
  • Retina Associates, Ltd., Elmhurst
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • University Retina and Macula Associates, Oak Forest
A’ fastadhSgrùdadh amharc
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07144137

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • University Retina and Macula Associates, Oak Forest
A’ fastadhÌre 1
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT03178149

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • University Retina & Macula Associates, Lemont
A’ fastadh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06662162

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • University of Illinois Chicago - UI Health, Chicago
A’ fastadhSgrùdadh amharc
Aoisean 6 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • University Retina and Macula Associates, Oak Forest
A’ fastadhÌre 1/2
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Illinois Retina Associates, Joliet
  • University Retina & Macula Associates, P.C., Lemont
A’ fastadhÌre 2/3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

  • Adverum site 179, Lemont
A’ fastadhÌre 2
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07630649

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Retina Associates, Ltd., Elmhurst
  • University Retina and Macula Associates, PC, Oak Forest
  • Illinois Retina Associates, Oak Park
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT07064759

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.